Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells

Ye Yang(Fudan University), Yan Zhu(Shanghai Institute of Planned Parenthood Research)
Frontiers in Pharmacology
April 30, 2025
Cited by 0


Related Papers